- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ALA dehydratase deficient porphyria (ADP) (ALAD)
Total 60125 results
-
Massachusetts General HospitalGlaxoSmithKlineRecruitingMetastatic Cancer | Central Nervous System CancerUnited States
-
Haihe Biopharma Co., Ltd.TerminatedBreast Cancer | Ovarian Cancer | Solid Tumor | Prostate Cancer | Endometrial CancerUnited States, Australia, China
-
Abramson Cancer Center at Penn MedicineActive, not recruitingProstate AdenocarcinomaUnited States
-
GlaxoSmithKlineSuspendedNeoplasmsGermany, Spain, United Kingdom, France, Hungary, Czechia
-
National Cancer Institute (NCI)Completed
-
PfizerMedivation, Inc.Completed
-
Alexander B Olawaiye, MDAstraZenecaRecruiting
-
Azienda Ospedaliero-Universitaria di ModenaRecruitingMetastatic Pancreatic Cancer | Advanced Pancreatic CancerItaly
-
Assistance Publique - Hôpitaux de ParisCompletedPregnant Women Undergoing TOP | TOP - Failed Attempted Termination of PregnancyFrance
-
Ruijin HospitalUnknownStomach Cancer | Gastric CancerChina
-
AbbVieCompleted
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Bayer; Janssen, LP; Prostate Cancer Clinical Trials ConsortiumCompletedStage IV Prostate Adenocarcinoma | Hormone-refractory Prostate Cancer | Prostate Carcinoma Metastatic to the BoneUnited States
-
Byondis B.V.CompletedSolid TumorUnited Kingdom, Belgium, Netherlands
-
Sun Yat-sen UniversityNot yet recruitingOvarian Cancer | Primary Peritoneal Cancer | High Grade Serous Adenocarcinoma of Ovary | High Grade Endometrioid Ovarian Cancer | Fallopian-tube CancerChina
-
AstraZenecaCompletedRefractory Solid Tumours | Relapsed Small Cell Lung Cancer (SCLC)United States, Canada
-
Ibrahim Halil SahinGlaxoSmithKlineNot yet recruitingMMR-D/MSI-H Colorectal CancersUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKlineRecruitingPenile CarcinomaUnited States
-
Brown UniversityBayer; The Miriam Hospital; Rhode Island Hospital; Clovis Oncology, Inc.Active, not recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Peking Union Medical College HospitalZai Lab (Shanghai) Co., Ltd.Not yet recruiting
-
AstraZenecaRecruitingOvarian CancerChina, Vietnam, Russian Federation, Ukraine, South Africa, Turkey, India, Peru, Colombia, Poland, Chile, Philippines
-
Tufts Medical CenterMerck Sharp & Dohme LLCActive, not recruitingNeutropenia | Cytomegalovirus Infections | Cytomegalovirus Disease | Heart Transplant Infection | Antiviral ToxicityUnited States
-
Fundacion CRIS de Investigación para Vencer el...GlaxoSmithKline; Apices Soluciones S.L.; IpsenActive, not recruiting
-
MedSIRTerminated
-
Hospices Civils de LyonCompleted
-
University of Michigan Rogel Cancer CenterPfizer; Acrotech Biopharma Inc.RecruitingMetastatic Breast Cancer | Metastatic Castration-resistant Prostate Cancer | Metastatic Ovarian CarcinomaUnited States
-
Dana-Farber Cancer InstituteJohns Hopkins University; GlaxoSmithKline; Translational Breast Cancer Research...RecruitingBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | HER2-negative Breast Cancer | Stage III Breast Cancer | Deleterious PALB2 Gene Mutation | Germline BRCA1 Gene Mutation | Germline BRCA2 Gene MutationUnited States
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.CompletedRecurrent Platinum Resistant Ovarian CancerUnited States
-
Marco ValgimigliCompletedCoronary Artery DiseaseItaly
-
BeiGeneActive, not recruiting
-
MedSIRNot yet recruitingOvarian Cancer | Oligometastatic Disease | Serous Ovarian Tumor
-
Xiaoxiang ChenNot yet recruitingOvarian Cancer | HRD | PARP InhibitorChina
-
Dana-Farber Cancer InstituteAstraZeneca; Osteosarcoma InstituteRecruitingOsteosarcoma | Osteosarcoma RecurrentUnited States
-
pharmaand GmbHCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer | Other Solid Tumor | Metastatic Castration-Resistant Prostate CancerIsrael, Italy, Canada, Russian Federation, United Kingdom, Poland
-
University of Colorado, DenverNational Cancer Institute (NCI); Clovis Oncology, Inc.Active, not recruitingMetastatic Endometrial CancerUnited States
-
University College, LondonRecruitingOvarian CancerAustralia, United Kingdom, Canada, New Zealand
-
Bai-Rong XiaActive, not recruiting
-
Vanderbilt-Ingram Cancer CenterAstraZeneca; Syndax PharmaceuticalsTerminatedFallopian Tube Cancer | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Recurrent Endometrial Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Primary Peritoneal... and other conditionsUnited States
-
Haider MahdiGlaxoSmithKline; Zenith EpigeneticsRecruitingOvarian Cancer | Recurrent Solid TumorsUnited States
-
AstraZenecaCompletedHead and Neck Squamous Cell CarcinomaTaiwan, United States, France
-
Tesaro, Inc.CompletedNeoplasms | Ovarian Neoplasms | Solid Tumor | Hepatic ImpairmentUnited States
-
PfizerMedivation, Inc.; Myriad Genetic Laboratories, Inc.TerminatedBreast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene MutationUnited States, Spain, United Kingdom, Germany, France
-
Zai Lab (Shanghai) Co., Ltd.Completed
-
Lisette NixonAstraZenecaUnknownNon-small Cell Lung CancerUnited Kingdom
-
SanofiCompletedPrimary Peritoneal Cancer | Advanced Epithelial Ovarian CancerUnited States
-
Do-Youn OhAstraZenecaActive, not recruitingAdvanced Gastric CancerKorea, Republic of
-
Monica MitaMerck Sharp & Dohme LLCRecruitingBreast CancerUnited States
-
Zhejiang Cancer HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.Not yet recruitingFemale Breast Cancer Patients | Histopathologically Confirmed Advanced HR +/HER2-invasive Breast Cancer | HRD Positive Advanced Breast Cancer
-
Lei LiRecruitingChemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian CancerChina
-
National Cancer Institute, NaplesRecruiting
-
Xiaoxiang ChenRecruitingOvarian Cancer | PARP Inhibitor | Clinical MarkerChina